Action Behavior Centers Marks One-Year Anniversary of Action Institute for Outcomes Research
AUSTIN, TX / ACCESS Newswire / August 22, 2025 / Action Behavior Centers (ABC), a leading provider of evidence-based applied...
Month: August 2025
Akanda Corp. Announces Closing of Share Exchange with First Towers and Fiber Corp.
First Towers develops, constructs and owns telecommunications infrastructure in MexicoAkanda Reaffirms its Continued Focus on the Growth of its Pre-Revenue...
Medical Device Contract Manufacturing Market worth $140.84 billion by 2030 with 10.9% CAGR | MarketsandMarkets™
DELRAY BEACH, Fla., Aug. 22, 2025 /PRNewswire/ -- The global Medical Device Contract Manufacturing Market, valued at US$78.58 billion in 2024, stood...
Software-Defined Perimeter (SDP) Market Growing at a 15.5%, Fueled by Rising Cybersecurity Threats and Cloud Adoption – Market Research Intellect
The growth of the Software-Defined Perimeter (SDP) market is driven by the rising need for advanced cybersecurity solutions to combat...
Accuro Electronic Medical Record Platform is now Integrated with PrescribeIT®, Canada’s National e-Prescribing Service
TORONTO, Aug. 22, 2025 /CNW/ - Canada Health Infoway (Infoway) and QHR Technologies Inc are pleased to announce the successful...
Dominari Holdings Announces Record Date for Cash Dividend
NEW YORK, Aug. 22, 2025 /PRNewswire/ -- Dominari Holdings Inc. (Nasdaq: DOMH) is pleased to announce that its board of...
MyFitnessPal Announces Its 2025 Summer Release
From smarter food logging to new ways to celebrate your progress, the latest updates make building healthy habits easier and...
Sarah Personette Appointed to LifeStance Board of Directors
Director William Miller to Step Down SCOTTSDALE, Ariz., Aug. 22, 2025 /PRNewswire/ -- LifeStance Health (NASDAQ: LFST), one of the nation's...
Bio-Thera and STADA Extend Biosimilars Alliance to Tocilizumab
Bio-Thera and STADA agree to extend their biosimilars alliance to cover tocilizumab, a targeted immunomodulatory monoclonal antibody directed against the...
The Realities of Working Motherhood in 2025 — and What Needs to Change
NEW YORK, Aug. 22, 2025 /PRNewswire/ -- As parents prepare for the chaos of back-to-school season, millions of working mothers are...
Psyence Group Inc. Enters Into a Letter of Intent to Acquire Goldcoast Resource Corp.
TORONTO, ON / ACCESS Newswire / August 22, 2025 / Psyence Group Inc. (CSE:PSYG) ("Psyence" or the "Company"), announces that...
Moderna Receives Health Canada Approval for Updated COVID-19 Vaccine Targeting SARS-CoV-2 Variant LP.8.1
All 2025 pre-filled syringe doses to be made in Canada, marking a domestic production milestone CAMBRIDGE, MA / ACCESS Newswire...
LivaNova to Present at Baird and Morgan Stanley Global Healthcare Conferences in September
LONDON--(BUSINESS WIRE)--$LIVN #cardiacsurgery--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced that Vladimir Makatsaria, Chief Executive Officer, and...
Clinical Computer Systems, Inc. (CCSI) Joins MEDITECH Alliance Program to Streamline Electronic Fetal Monitoring with the OBIX® System
HOFFMAN ESTATES, Ill.--(BUSINESS WIRE)--Clinical Computer Systems, Inc. (CCSI), a leading provider of electronic fetal monitoring software, is proud to announce...
Medical Care Technologies Inc. (OTC Pink:MDCE) Powers Forward in 2025 With Patent-Pending AI, Explosive Revenue Growth, and Historic Auction Showcase
Rebounding with Strength: AI Innovation, Health Care Tools and Sports Legacy Drive MDCE's Expansion MESA, AZ / ACCESS Newswire /...
Jyong Biotech Ltd. Participated in the 22nd Urological Association of Asia Congress to Display the Clinical Data for its Phase III Studies of BOTRESO and Phase II Study of MCS-8 (PCP)
New Taipei City, Taiwan, Aug. 22, 2025 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the “Company”, “Jyong Biotech”), a...
Flaggemelding
Hawkeye Invest AS, et selskap som kontrolleres av Øystein Barmen, har i dag solgt 2 000 000 aksjer i PCI...
Century Therapeutics to Present at H.C. Wainwright 27th Annual Global Investment Conference
PHILADELPHIA, Aug. 22, 2025 (GLOBE NEWSWIRE) -- Century Therapeutics, Inc. (‘Century’, NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent...
BlossomHill Therapeutics Announces First Patient Dosed in Expansion Cohorts of the Phase 1/2 SOLARA Trial, Evaluating BH-30643 in Advanced EGFR-mutant Non-Small Cell Lung Cancer
SAN DIEGO, Aug. 22, 2025 (GLOBE NEWSWIRE) -- BlossomHill Therapeutics, Inc., a privately-held, clinical-stage biotechnology company focused on the design...
Repligen Corporation to Present at Upcoming September Conferences
WALTHAM, Mass., Aug. 22, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership,...